
vTv Therapeutics Inc.
vTv Therapeutics Inc. (VTVT)
WebsitePrice
Market cap
Next catalystExpected 2H 2027Cadisegliatin — Middle East Phase 2 with G42 · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Partner / License out
PreINDP1P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved